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The study design: Non-blinded randomised controlled trial with intention-to-treat analysis.
The study patients: Adult (>18 years of age) medical intensive care patients requiring invasive MV. Exclusion criteria were: • patients receiving neuromuscular blockade agents • patients with severe chronic neuro-cognitive dysfunction requiring assistance with most activities of daily living • patients transferred from another ICU • patients who had a tracheostomy at the time of study enrolment • patients for whom consent could not be obtained before the time point when sedation was to be interrupted.
Control group -daily interruption of sedation (DIS) (n=36). DIS was performed initially as outlined by Kress. 1 Forty-eight hours after initiation of MV, all sedatives and opioids administered as either continuous infusions or bolus infusions were discontinued until the patient was awake or agitated as defined by the Richmond Agitation-Sedation Scale (RASS). This was observed by a study investigator. 'Awake' was defined as being able to perform at least three of the following commands: (a) open eyes, (b) visually track the investigator, (c) stick out tongue, and (d) squeeze hand. Study investigators decided if and when to resume sedation. The DIS group were not managed with the SA but at the discretion of the ICU team targeting a RASS score of -2 to -3. Clinicians titrated sedatives and opioids throughout the day independently of the study investigators. A cardiorespiratory 'get-out' clause (RR >35/min for 5 minutes, HR >140, SBP>180 mm Hg) was also added after the third patient developed uncontrolled hypertension and ventilatory asynchrony requiring muscle relaxants.
Experimental group -sedation algorithm (SA) (n=38). The local multidisciplinary team developed a SA with goals to maximise the use of boluses, minimise the duration of continuous intravenous infusions of sedation and to treat pain with opioids. It included attempts (four times daily) to decrease sedation. The RASS was used to measure the sedation level, and sedation was titrated to a goal RASS score of -2 to -3 (approximates to Ramsay score of 3-4) unless otherwise specified by the ICU team. Educational training and three months' experience of the algorithm were provided prior to trial commencement. There was daily support for nurses administering the algorithm. The algorithm was audited by the study investigators on two occasions per day at the discretion of investigators.
EBM questions:
Do the methods allow the accurate testing of the hypothesis?
No. The study investigators were not blinded to sedation method. There were significant differences in the management of the two groups, apart from the study interventions that are potential sources of bias:
• three months training with SA was provided prior to the study commencing. There is no mention of training for use of DIS.
• The SA was controlled by the nursing staff, DIS was controlled by a study investigator.
• The SA was developed by a multidisciplinary team, which would have generated staff 'buy-in'; the DIS algorithm was simply adopted without a trial period (in fact, after use with only two patients, it needed to be amended).
If we compare DIS performance in this study with two previous studies, this study' s group outcome is poor despite similar demographics and illness severity, suggesting that it could have been delivered more effectively (see Table) 
